Menu

Blog

Archive for the ‘economics’ category: Page 14

May 2, 2020

The US already has the technology to test millions of people a day

Posted by in categories: biotech/medical, economics, government

There is widespread agreement that the only way to safely reopen the economy is through a massive increase in testing. The US needs to test millions of people per day to effectively track and then contain the covid-19 pandemic.

This is a tall order. The country tested only around 210,000 people per day last week, and the pace is not increasing fast enough to get to millions quickly.

The urgency to do better is overwhelmingly bipartisan, with the most recent legislation adding $25 billion for testing a few days ago. Fears are growing, however, that testing might not scale in time to make a difference. As Senators Lamar Alexander and Roy Blunt wrote last week, “We have been talking with experts across the government and the private sector to find anyone who believes that current technology can produce the tens of millions of tests necessary to put this virus behind us. Unfortunately, we have yet to find anyone to do so.”

Continue reading “The US already has the technology to test millions of people a day” »

May 1, 2020

Abu Dhabi stem cell center develops ‘promising’ new COVID-19 treatment

Posted by in categories: biotech/medical, economics

“According to WAM, stem cells are extracted from the patient’s blood and then reintroduced in an “activated” state to the lungs through inhalation after being nebulized into a fine mist.

ADSCC researchers said the mist had a therapeutic effect, helping to regenerate lung cells and alter the response of the immune system to stop it from overreacting to the COVID-19 infection and causing more damage to healthy cells.

The treatment has undergone and successfully passed the first stage of clinical trials with further tests to demonstrate its effectiveness being carried out over the next two weeks.”

Continue reading “Abu Dhabi stem cell center develops ‘promising’ new COVID-19 treatment” »

Apr 30, 2020

Reading Islamophobia in Hindutva: An Analysis of Narendra Modi’s Political Discourse

Posted by in categories: economics, entertainment

What are some of ways that technology can be used to combat things like racism, bipartisan politics, Islamophobia, antisemitism, and extreme prejudice? Especially when these things are systemically embedded in certain cultures to the point that rationality seems to fly out the window? I see conversations on social media in peaceful international groups such as this one as a great potential stepping stone to mediate the tension between groups who seem to be devoted to blind hatred for one another. What are some other ways technology can advance social and political sciences?

“This article analyzes the narratives of Islamophobia in Hindu Nationalism (Hindutva). Specifically, it analyzes how Indian Prime Minister Narendra Modi, from the Hindu nationalist Bharatiya Janata Party (BJP), articulates Islamophobia in his speeches, interviews, and podcasts. In total, a discourse analysis of 35 such documents has been conducted. Conceptually, this article applies the notion of language-games to understand how Modi articulates Islamophobia. The article contends that while Modi’s Islamophobia is executed subtly, it is nonetheless a function of the way in which Hindutva conceives of Muslims as subordinate to Hindus. Two Islamophobic narratives in Modi’s political discourse have been mapped out: the erasure of Indian Muslim histories in Modi’s economic development agenda, and the characterization of Hinduism as having a taming effect on Islam in India. The article provides a conceptual overview of language-games and a review of how Hindutva defines Hindus and Muslims, before analyzing how Modi articulates Islamophobia. The article concludes by suggesting that a Hindutva-driven Islamophobia may have permeated into the Hindu mainstream.”

Apr 29, 2020

The US government is helping get cash to private space companies, replacing frozen venture capital

Posted by in categories: biotech/medical, business, economics, finance, government, military

Investment in the fast-growing space industry was booming well into the first quarter of 2020 but private capital has largely frozen as the coronavirus pandemic strikes the U.S., leading both civil and military agencies to step up funding for corporate partners.

“We kicked into high gear as soon as it was apparent a lot of companies were not going to be able to conduct business as usual due to distancing requirements,” Mike Read, International Space Station business and economic development manager at NASA’s Johnson Space Center, told CNBC.

U.S. equity investment in space companies totaled $5.4 billion across 36 deals in the first quarter, according to a report Friday by NYC-based firm Space Capital. But the second quarter is likely to just see a fraction of that investment, according to Space Capital managing partner Chad Anderson, as deal flow in the U.S. will follow China’s path. Chinese investment in space was climbing by record amounts until the first quarter, when “activity in China was basically shut off,” Anderson said.

Continue reading “The US government is helping get cash to private space companies, replacing frozen venture capital” »

Apr 29, 2020

Dr Stanley Plotkin: The Godfather of Vaccines

Posted by in categories: biotech/medical, economics

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Stanley Plotkin, Professor Emeritus at both Wistar Institute and the University of Pennsylvania and consultant to the vaccine industry.

Ira Pastor Comments:

Continue reading “Dr Stanley Plotkin: The Godfather of Vaccines” »

Apr 28, 2020

Nancy Pelosi Comes Out In Support of Universal Guaranteed Income

Posted by in category: economics

Nancy Pelosi came out in support of universal guaranteed income for Americans, building upon the vision of former 2020 candidate Andrew Yang.

Apr 27, 2020

See a string of lights in the sky? It was probably SpaceX’s ‘Starlink’ satellites

Posted by in categories: economics, satellites

We’re getting many calls and emails from WGN viewers who say they spotted a strange string of lights crossing the night sky on Sunday.

No, it’s not planes flying in formation or a meteor shower. It’s actually a satellite string that’s part of SpaceX’s “Starlink” project. You can read more about it below.

While much of the world economy stands still, SpaceX is running full speed ahead.

Continue reading “See a string of lights in the sky? It was probably SpaceX’s ‘Starlink’ satellites” »

Apr 25, 2020

$110 Trillion Renewables Stimulus Package Could Create 50 Million Jobs

Posted by in categories: biotech/medical, economics, employment

Even giant economic powerhouses have not been spared, with California—one of the wealthiest states in the United States thanks to its booming tech sector—having obliterated all its job growth over the last decade in just two months.

But now a renewable energy think-tank says directing those stimulus dollars to renewable energy investments could not only help tackle global climate emergency but spur massive economic gains post-Covid-19 for decades to come.

The International Renewable Energy Agency (IRENA) —an organization dedicated to promoting global adoption of renewable energy and facilitating sustainable use—says that it will cost the global economy $95 trillion to help return things to normal.

Continue reading “$110 Trillion Renewables Stimulus Package Could Create 50 Million Jobs” »

Apr 25, 2020

Smash and Grab – The UK’s Money Laundering Machine

Posted by in categories: business, economics, government

Download the full report here.

In 2017, Bellingcat and Transparency International UK published their joint report, “Offshore in the UK”, describing the phenomenon of Scottish Limited Partnerships (“SLPs”) and their use as a mechanism in global money laundering scandals and a range of illicit activities. Since then, SLPs have continued to be implicated in further scandals, perhaps most notably the Azerbaijani Laundromat, a scheme where $2.9 billion was laundered through UK companies.

In the same year, SLPs became obliged to register their Person of Significant Control at Companies House, and the boom in registrations ended. The government subsequently ran a public consultation into limited partnerships, and published its conclusions in December 2018. Currently, SLP registrations are at their lowest level since 2010. Nevertheless, a lack of regulation allowed thousands of opaquely owned partnerships, typically with no tangible link to the Uk, to flourish over a seven year period. We do not have the details of the business activities of these SLPs, who controlled them, or who their true beneficial owners are.

Continue reading “Smash and Grab – The UK’s Money Laundering Machine” »

Apr 24, 2020

Rapid development of an inactivated vaccine for SARS-CoV-2

Posted by in categories: biotech/medical, economics, health

April 2020


The COVID-19 pandemic caused by SARS-CoV-2 has brought about an unprecedented crisis, taking a heavy toll on human health, lives as well as the global economy. There are no SARS-CoV-2-specific treatments or vaccines available due to the novelty of this virus. Hence, rapid development of effective vaccines against SARS-CoV-2 is urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies potently neutralized 10 representative SARS-CoV-2 strains, indicative of a possible broader neutralizing ability against SARS-CoV-2 strains circulating worldwide. Immunization with two different doses (3μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without any antibody-dependent enhancement of infection. Systematic evaluation of PiCoVacc via monitoring clinical signs, hematological and biochemical index, and histophathological analysis in macaques suggests that it is safe. These data support the rapid clinical development of SARS-CoV-2 vaccines for humans.

One Sentence Summary A purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc) confers complete protection in non-human primates against SARS-CoV-2 strains circulating worldwide by eliciting potent humoral responses devoid of immunopathology.

The authors have declared no competing interest.

Continue reading “Rapid development of an inactivated vaccine for SARS-CoV-2” »

Page 14 of 139First1112131415161718Last